Demand For Gene Therapies To Prompt Surge In Pharma M & A

Big pharma companies need to buy innovation, biotech companies are getting sky-high valuations, and 2018 is shaping up to be the second biggest M&A year for the sector on record.

Source: Forbes.com Healthcare News - June 19, 2018 Category: Pharmaceuticals Authors: Mergermarket, Contributor Tags: NASDAQ:SYNH NASDAQ:CELG NYSE:NVS Source Type: news